Literature DB >> 3976564

The prevalence of vitamin K deficiency in chronic gastrointestinal disorders.

S D Krasinski, R M Russell, B C Furie, S F Kruger, P F Jacques, B Furie.   

Abstract

Vitamin K deficiency results in the appearance of abnormal prothrombin, deficient in gamma-carboxyglutamic acid, in the blood. The presence of abnormal prothrombin can be eliminated or lowered by the administration of vitamin K. Since the abnormal prothrombin antigen assay is approximately 1000-fold more sensitive than the prothrombin time for the diagnosis of vitamin K deficiency, this assay was used to evaluate patients with intestinal abnormalities. Vitamin K deficiency was found in 18 of 58 patients (31%) with chronic gastrointestinal disease and/or resection. All patients with vitamin K deficiency had either Crohn's disease involving the ileum or ulcerative colitis treated with sulfasalazine or antibiotics. Abnormal prothrombin levels returned toward normal in patients treated with vitamin K but not in patients who were not treated with vitamin K. The mean plasma vitamin E level in patients with vitamin K deficiency was significantly lower than in vitamin-K sufficient patients (p less than 0.01). We conclude that certain chronic forms of gastrointestinal disorders are associated with vitamin K deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976564     DOI: 10.1093/ajcn/41.3.639

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  19 in total

Review 1.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

2.  Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy.

Authors:  Amosy Ephreim M'Koma
Journal:  Int J Colorectal Dis       Date:  2006-01-26       Impact factor: 2.571

3.  Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?

Authors:  E J Schoon; M C Müller; C Vermeer; L J Schurgers; R J Brummer; R W Stockbrügger
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.

Authors:  I J Mackie; K Walshe; H Cohen; P McCarthy; M Shearer; S D Scott; S J Karran; S J Machin
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

Review 5.  Vitamins and Minerals in Inflammatory Bowel Disease.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

6.  Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis.

Authors:  P G Jorens; C R Hermans; I Haber; M M Kockx; J Vermylen; G A Parizel
Journal:  Blut       Date:  1990-11

7.  High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.

Authors:  A Kuwabara; K Tanaka; N Tsugawa; H Nakase; H Tsuji; K Shide; M Kamao; T Chiba; N Inagaki; T Okano; S Kido
Journal:  Osteoporos Int       Date:  2008-09-30       Impact factor: 4.507

8.  Vitamin K deficiency bleeding presenting as impending brain herniation.

Authors:  H Gopakumar; R Sivji; P K Rajiv
Journal:  J Pediatr Neurosci       Date:  2010-01

9.  Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse.

Authors:  Susan Elaine Fugate; April Michelle Ramsey
Journal:  J Thromb Thrombolysis       Date:  2004-06       Impact factor: 2.300

10.  A Case of Transient Ischemic Attack in a patient with Ulcerative Colitis.

Authors:  A Valavanis; T Tegos
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.